ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $510,732 | +10.5% | 12,592 | -9.8% | 0.01% | 0.0% |
Q3 2022 | $462,000 | -9.2% | 13,964 | -3.4% | 0.01% | -11.1% |
Q2 2022 | $509,000 | -25.5% | 14,449 | -2.7% | 0.01% | -10.0% |
Q1 2022 | $683,000 | -31.1% | 14,845 | -0.8% | 0.01% | -23.1% |
Q4 2021 | $992,000 | +2.1% | 14,960 | -3.9% | 0.01% | -7.1% |
Q3 2021 | $972,000 | -27.8% | 15,563 | -4.3% | 0.01% | -26.3% |
Q2 2021 | $1,346,000 | +22.6% | 16,256 | -1.9% | 0.02% | +11.8% |
Q1 2021 | $1,098,000 | -16.1% | 16,564 | -2.8% | 0.02% | -22.7% |
Q4 2020 | $1,308,000 | +74.9% | 17,048 | -1.8% | 0.02% | +46.7% |
Q3 2020 | $748,000 | -0.9% | 17,362 | -0.6% | 0.02% | -6.2% |
Q2 2020 | $755,000 | +52.2% | 17,471 | +1.2% | 0.02% | +33.3% |
Q1 2020 | $496,000 | -55.6% | 17,256 | -1.9% | 0.01% | -50.0% |
Q4 2019 | $1,116,000 | +120.1% | 17,599 | -2.1% | 0.02% | +118.2% |
Q3 2019 | $507,000 | +4.3% | 17,981 | -1.9% | 0.01% | 0.0% |
Q2 2019 | $486,000 | +23.0% | 18,323 | -14.7% | 0.01% | +22.2% |
Q1 2019 | $395,000 | +18.3% | 21,481 | -20.1% | 0.01% | +12.5% |
Q4 2018 | $334,000 | – | 26,872 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,264 | $54,392,000 | 33.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $216,228,000 | 28.00% |
L1 Capital Pty Ltd | 296,024 | $19,629,000 | 4.93% |
Aquilo Capital Management, LLC | 407,926 | $27,050,000 | 4.89% |
Evolutionary Tree Capital Management, LLC | 72,948 | $4,837,000 | 2.86% |
ACUTA CAPITAL PARTNERS, LLC | 108,000 | $7,161,000 | 2.58% |
First Light Asset Management, LLC | 536,836 | $35,598,000 | 2.36% |
Parkman Healthcare Partners LLC | 70,089 | $4,648,000 | 1.08% |
Hood River Capital Management LLC | 357,082 | $23,678,000 | 0.76% |
Vanguard Capital Wealth Advisors | 11,099 | $703,565,000 | 0.60% |